| pubmed-article:2869344 | rdf:type | pubmed:Citation | lld:pubmed |
| pubmed-article:2869344 | lifeskim:mentions | umls-concept:C0036323 | lld:lifeskim |
| pubmed-article:2869344 | lifeskim:mentions | umls-concept:C0029994 | lld:lifeskim |
| pubmed-article:2869344 | lifeskim:mentions | umls-concept:C0006137 | lld:lifeskim |
| pubmed-article:2869344 | lifeskim:mentions | umls-concept:C0920467 | lld:lifeskim |
| pubmed-article:2869344 | lifeskim:mentions | umls-concept:C0220825 | lld:lifeskim |
| pubmed-article:2869344 | pubmed:issue | 8482 | lld:pubmed |
| pubmed-article:2869344 | pubmed:dateCreated | 1986-4-22 | lld:pubmed |
| pubmed-article:2869344 | pubmed:abstractText | This prospective study has shown that oxamniquine treatment controlled endemic schistosomiasis mansoni in a defined rural population in Castro Alves, north-east Brazil. Data before and after treatment spanning 11 years were collected for a cohort of 191 residents. Before treatment (1974-77), the cohort was heavily infected and the prevalence of associated hepatomegaly (greater than 86%) and splenomegaly (greater than 17%) was stable. The cohort was treated when oxamniquine became available in 1977; during the next 8 years, over 80% received further treatments from the Brazilian programme for the control of schistosomiasis. With treatment, the incidence of splenomegaly fell (10% to 2%) and the splenomegaly regression rate increased (43% to 91%). Declining disease rates were coincident with substantial falls in the prevalence and intensity of Schistosoma mansoni infections. The final prevalence rates for hepatomegaly (31%) and splenomegaly (3%) in Castro Alves approached the corresponding rates of 10% and 1% in a comparable uninfected control population. | lld:pubmed |
| pubmed-article:2869344 | pubmed:language | eng | lld:pubmed |
| pubmed-article:2869344 | pubmed:journal | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:2869344 | pubmed:citationSubset | AIM | lld:pubmed |
| pubmed-article:2869344 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:2869344 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:2869344 | pubmed:status | MEDLINE | lld:pubmed |
| pubmed-article:2869344 | pubmed:month | Mar | lld:pubmed |
| pubmed-article:2869344 | pubmed:issn | 0140-6736 | lld:pubmed |
| pubmed-article:2869344 | pubmed:author | pubmed-author:MaguireJ HJH | lld:pubmed |
| pubmed-article:2869344 | pubmed:author | pubmed-author:MottK EKE | lld:pubmed |
| pubmed-article:2869344 | pubmed:author | pubmed-author:HoffRR | lld:pubmed |
| pubmed-article:2869344 | pubmed:author | pubmed-author:SleighA CAC | lld:pubmed |
| pubmed-article:2869344 | pubmed:author | pubmed-author:da França... | lld:pubmed |
| pubmed-article:2869344 | pubmed:issnType | Print | lld:pubmed |
| pubmed-article:2869344 | pubmed:day | 22 | lld:pubmed |
| pubmed-article:2869344 | pubmed:volume | 1 | lld:pubmed |
| pubmed-article:2869344 | pubmed:owner | NLM | lld:pubmed |
| pubmed-article:2869344 | pubmed:authorsComplete | Y | lld:pubmed |
| pubmed-article:2869344 | pubmed:pagination | 635-7 | lld:pubmed |
| pubmed-article:2869344 | pubmed:dateRevised | 2004-11-17 | lld:pubmed |
| pubmed-article:2869344 | pubmed:meshHeading | pubmed-meshheading:2869344-... | lld:pubmed |
| pubmed-article:2869344 | pubmed:meshHeading | pubmed-meshheading:2869344-... | lld:pubmed |
| pubmed-article:2869344 | pubmed:meshHeading | pubmed-meshheading:2869344-... | lld:pubmed |
| pubmed-article:2869344 | pubmed:meshHeading | pubmed-meshheading:2869344-... | lld:pubmed |
| pubmed-article:2869344 | pubmed:meshHeading | pubmed-meshheading:2869344-... | lld:pubmed |
| pubmed-article:2869344 | pubmed:meshHeading | pubmed-meshheading:2869344-... | lld:pubmed |
| pubmed-article:2869344 | pubmed:meshHeading | pubmed-meshheading:2869344-... | lld:pubmed |
| pubmed-article:2869344 | pubmed:meshHeading | pubmed-meshheading:2869344-... | lld:pubmed |
| pubmed-article:2869344 | pubmed:meshHeading | pubmed-meshheading:2869344-... | lld:pubmed |
| pubmed-article:2869344 | pubmed:meshHeading | pubmed-meshheading:2869344-... | lld:pubmed |
| pubmed-article:2869344 | pubmed:meshHeading | pubmed-meshheading:2869344-... | lld:pubmed |
| pubmed-article:2869344 | pubmed:meshHeading | pubmed-meshheading:2869344-... | lld:pubmed |
| pubmed-article:2869344 | pubmed:meshHeading | pubmed-meshheading:2869344-... | lld:pubmed |
| pubmed-article:2869344 | pubmed:meshHeading | pubmed-meshheading:2869344-... | lld:pubmed |
| pubmed-article:2869344 | pubmed:meshHeading | pubmed-meshheading:2869344-... | lld:pubmed |
| pubmed-article:2869344 | pubmed:meshHeading | pubmed-meshheading:2869344-... | lld:pubmed |
| pubmed-article:2869344 | pubmed:year | 1986 | lld:pubmed |
| pubmed-article:2869344 | pubmed:articleTitle | Manson's schistosomiasis in Brazil: 11-year evaluation of successful disease control with oxamniquine. | lld:pubmed |
| pubmed-article:2869344 | pubmed:publicationType | Journal Article | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:2869344 | lld:pubmed |
